# Kraig Biocraft Laboratories, Inc.: Form 10-Q/A for the period ended Jun 30, 2012

- Company: [Kraig Biocraft Laboratories, Inc.](/companies/kblb.md) (CIK 1413119)
- Form: 10-Q/A
- Filed: 2012-09-10
- Accepted by EDGAR: Sep 10, 2012, 12:10 ET
- Period: 2012-06-30
- Accession: 0001354488-12-004752
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1413119/000135448812004752/kblb_10qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1413119/000135448812004752/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2012-04-01 to 2012-06-30 | $0 | us-gaap:SalesRevenueNet |
| Revenue | 6 months, 2012-01-01 to 2012-06-30 | $0 | us-gaap:SalesRevenueNet |
| Research and development | 3 months, 2012-04-01 to 2012-06-30 | $210.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2012-01-01 to 2012-06-30 | $210.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2012-04-01 to 2012-06-30 | −$501.8k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2012-01-01 to 2012-06-30 | −$624.9k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2012-04-01 to 2012-06-30 | $15.0k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2012-01-01 to 2012-06-30 | $30.1k | us-gaap:InterestExpense |
| Income tax | 3 months, 2012-04-01 to 2012-06-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2012-01-01 to 2012-06-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2012-04-01 to 2012-06-30 | −$513.8k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2012-01-01 to 2012-06-30 | −$651.8k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2012-04-01 to 2012-06-30 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2012-01-01 to 2012-06-30 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months, 2012-01-01 to 2012-06-30 | −$339.2k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2012-01-01 to 2012-06-30 | $0 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2012-06-30 | $253.9k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-06-30 | $264.0k | us-gaap:AssetsCurrent |
| Total assets | at 2012-06-30 | $283.3k | us-gaap:Assets |
| Current liabilities | at 2012-06-30 | $920.4k | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2012-06-30 | $931.6k | us-gaap:Liabilities |
| Shareholders' equity | at 2012-06-30 | −$648.3k | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1413119/000135448812004752/kblb_10qa.htm

Filed Sep 10, 2012.
Source: SEC EDGAR, the filing index for accession 0001354488-12-004752. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.
